Thiazolidinediones
- PMID: 15647589
- DOI: 10.1056/NEJM200501133520222
Thiazolidinediones
Comment on
-
Thiazolidinediones.N Engl J Med. 2004 Sep 9;351(11):1106-18. doi: 10.1056/NEJMra041001. N Engl J Med. 2004. PMID: 15356308 Review. No abstract available.
Similar articles
-
Effect of thiazolidinediones on lipid profile.CMAJ. 2005 Aug 16;173(4):344; author reply 344-5. doi: 10.1503/cmaj.1050034. CMAJ. 2005. PMID: 16103495 Free PMC article. No abstract available.
-
[Pioglitazone].Nihon Rinsho. 2012 May;70 Suppl 3:620-6. Nihon Rinsho. 2012. PMID: 22768588 Japanese. No abstract available.
-
A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.J Clin Pharmacol. 2008 Aug;48(8):999-1002. doi: 10.1177/0091270008319791. J Clin Pharmacol. 2008. PMID: 18650500 No abstract available.
-
Cardiovascular effects of troglitazone.Ann Pharmacother. 1999 Feb;33(2):229-32. doi: 10.1345/aph.18028. Ann Pharmacother. 1999. PMID: 10084419 Review. No abstract available.
-
Thiazolidinediones.N Engl J Med. 2004 Sep 9;351(11):1106-18. doi: 10.1056/NEJMra041001. N Engl J Med. 2004. PMID: 15356308 Review. No abstract available.
Cited by
-
Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.J Affect Disord. 2012 Feb;136(3):1164-73. doi: 10.1016/j.jad.2011.06.033. Epub 2011 Jul 22. J Affect Disord. 2012. PMID: 21782251 Free PMC article. Clinical Trial.
-
CaMKK2 Signaling in Metabolism and Skeletal Disease: a New Axis with Therapeutic Potential.Curr Osteoporos Rep. 2019 Aug;17(4):169-177. doi: 10.1007/s11914-019-00518-w. Curr Osteoporos Rep. 2019. PMID: 31115859 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical